Ascendis Pharma Files 6-K for S-8 Registration Updates
Ticker: ASND · Form: 6-K · Filed: Jun 27, 2025 · CIK: 1612042
Sentiment: neutral
Topics: sec-filing, registration, employee-benefits
TL;DR
Ascendis Pharma filed a 6-K to keep its employee stock plans registered with the SEC.
AI Summary
Ascendis Pharma A/S filed a Form 6-K on June 27, 2025, to incorporate by reference into its existing Form S-8 registration statements. These S-8 filings are related to employee stock benefit plans and were originally filed between 2015 and 2022. The 6-K itself does not contain new financial information but serves to update or maintain the effectiveness of those prior filings.
Why It Matters
This filing is procedural, ensuring that Ascendis Pharma's employee stock plans remain properly registered with the SEC, which is crucial for the issuance of new shares to employees.
Risk Assessment
Risk Level: low — This is a routine administrative filing related to existing registrations and does not introduce new financial or operational risks.
Key Numbers
- 20 — Public Document Count (Indicates the number of documents included in this filing.)
Key Players & Entities
- Ascendis Pharma A/S (company) — Registrant
- 001-36815 (company) — SEC File Number
- Form S-8 (company) — Registration Statement Type
- June 27, 2025 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed to incorporate by reference into Ascendis Pharma A/S's existing registration statements on Form S-8, which relate to employee stock benefit plans.
What are the Form S-8 registration statements used for?
Form S-8 registration statements are used by companies to register securities to be offered to employees under employee stock purchase or option plans.
When were the referenced Form S-8 registration statements originally filed?
The referenced Form S-8 registration statements were originally filed between 2015 and 2022, as indicated by the registration numbers listed.
Does this 6-K filing contain new financial results for Ascendis Pharma?
No, this Form 6-K filing does not appear to contain new financial results; it is primarily for incorporating previous filings into current registration statements.
What is the SEC file number for Ascendis Pharma A/S?
The SEC file number for Ascendis Pharma A/S is 001-36815.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 27, 2025 regarding Ascendis Pharma A/S (ASND).